Peripheral arterial disease increases the risk of multidrug-resistant bacteria and amputation in diabetic foot infections

被引:17
作者
Aysert Yildiz, Pinar [1 ]
Ozdil, Tugba [2 ]
Dizbay, Murat [3 ]
Guzel Tukccan, Ozlem [3 ]
Hizel, Kenan [3 ]
机构
[1] Dr Nafiz Korez Sincan State Hosp, Dept Infect Dis, Ankara, Turkey
[2] Karaman State Hosp, Dept Infect Dis, Karaman, Turkey
[3] Gazi Univ, Sch Med, Dept Clin Microbiol & Infect Dis, Ankara, Turkey
关键词
Diabetic foot; peripheral arterial disease; infection; ULCERS; THERAPY; MICROBIOLOGY; MULTICENTER; TRIAL;
D O I
10.3906/sag-1803-217
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/aim: The aim of this study was to investigate the microbiological profile and resistance rates of diabetic foot infections (DFIs) and to determine the effect of peripheral arterial disease (PAD) on the microbiology, clinical condition, and treatment outcomes. Materials and methods: Characteristics, laboratory and imaging data, and the treatment modalities of patients admitted to our hospital with a diagnosis of DFI (PEDIS classification 3-4) during 2005-2016 were analyzed according to the presence of PAD. Results: Of 112 patients who were included in this study, 86 (76.8%) had PAD. Patients with PAD were older and had higher amputation rates (P < 0.05). A microbiological profile of patients revealed a predominance of gram-positive bacteria (57.1%). Staphylococcus aureus and Streptococcus spp. were the most frequently encountered bacteria. Incidence of Pseudomonas spp. infection was higher in the PAD group (P < 0.05). Of all patients, 24.1% had multidrug-resistant (MDR) microorganisms in their wound cultures. Presence of MDR bacteria in patients with PAD was 4.9-fold higher than that in patients without PAD (P < 0.05). Conclusion: This retrospective study indicates that PAD has a significant role, especially in elderly patients with DFIs. Patients should be promptly evaluated and treated for PAD to prevent infections with resistant microorganisms and limb loss.
引用
收藏
页码:845 / 850
页数:6
相关论文
共 34 条
[1]  
Albrant DH, 2000, J AM PHARM ASSOC, V40, P467
[2]  
ALPIZAR M, 1995, DIABETIC MED, V12, P14
[3]  
[Anonymous], MED SCI
[4]  
Bansal E, 2008, INDIAN J PATHOL MICR, V51, P204
[5]   Diabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting [J].
Cade, W. Todd .
PHYSICAL THERAPY, 2008, 88 (11) :1322-1335
[6]   Bacteriology of moderate-to-severe diabetic foot infections and in vitro activity of antimicrobial agents [J].
Citron, Diane M. ;
Goldstein, Ellie J. C. ;
Merriam, C. Vreni ;
Lipsky, Benjamin A. ;
Abramson, Murray A. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2007, 45 (09) :2819-2828
[7]   Diabetic foot infections. Prevalence and antibiotic sensitivity of the causative microorganisms [J].
de Alcala Martinez-Gomez, Diego ;
Ramirez-Almagro, Cristobal ;
Campillo-Soto, Alvaro ;
Morales-Cuenca, German ;
Pagan-Ortiz, Jorge ;
Luis Aguayo-Albasini, Jose .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2009, 27 (06) :317-321
[8]   Methicillin-Resistant Staphylococcus aureus in Diabetic Foot Infections [J].
Eleftheriadou, Loanna ;
Tentolouris, Nicholas ;
Argiana, Vasiliki ;
Jude, Edward ;
Boulton, Andrew J. .
DRUGS, 2010, 70 (14) :1785-1797
[9]   A prospective, multi-center study: factors related to the management of diabetic foot infections [J].
Ertugrul, B. M. ;
Oncul, O. ;
Tulek, N. ;
Willke, A. ;
Sacar, S. ;
Tunccan, O. G. ;
Yilmaz, E. ;
Kaya, O. ;
Ozturk, B. ;
Turhan, O. ;
Yapar, N. ;
Ture, M. ;
Akin, F. .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2012, 31 (09) :2345-2352
[10]   A clinico-microbiological study of diabetic foot ulcers in an Indian tertiary care hospital [J].
Gadepalli, Ravisekhar ;
Dhawan, Benu ;
Sreenivas, Vishnubhatla ;
Kapil, Arti ;
Ammini, A. C. ;
Chaudhry, Rama .
DIABETES CARE, 2006, 29 (08) :1727-1732